| Shareholder | |||
|---|---|---|---|
| 康心汕Executive Director | 35.16% | 27.68M | |
| Feng Yan Executive Director | 35.16% | 27.68M | |
| Tu Liandong | 20.33% | 16.00M | |
| 福建省投资开发集团有限责任公司 | 8.89% | 7.00M | |
| 厦门泰瑞和投资合伙企业(有限合伙) | 6.35% | 5.00M | |
| 福州市金融控股集团有限公司 | 5.95% | 4.68M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of HAIXI PHARMA (02637) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

